Evidence map›Paper›PMID 38444948›Full record

ArticleRisk management and healthcare policy2024

Optimization of Diagnosis-Related Groups for 14,246 Patients with Uterine Leiomyoma in a Single Center in Western China Using a Machine Learning Model.

Yuan Ma, Li Li, Li Yu, Wei He, Ling Yi, Yuxin Tang, Jijie Li, Zhigang Zhong, Meixian Wang, Shiyao Huang and 3 more

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuan MaDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.ORCID 0000-0003-4065-1441
Li LiDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Li YuDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Wei HeDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Ling YiDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Yuxin TangDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Jijie LiDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Zhigang ZhongDepartment of Prevention, Office of Cancer Prevention and Treatment, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China.
Meixian WangNational Center for Birth Defects Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Shiyao HuangChinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Yiquan XiongChinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Pei XiaoMedical Insurance Office, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Yuxiang HuangDepartment of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Uterine leiomyoma (UL) is one of the most common benign tumors in women, and its incidence is gradually increasing in China. The clinical complications of UL have a negative impact on women's health, and the cost of treatment poses a significant burden on patients. Diagnosis-related groups (DRG) are internationally recognized as advanced healthcare payment management methods that can effectively reduce costs. However, there are variations in the design and grouping rules of DRG policies across different regions. Therefore, this study aims to analyze the factors influencing the hospitalization costs of patients with UL and optimize the design of DRG grouping schemes to provide insights for the development of localized DRG grouping policies. Methods: The Mann-Whitney Results: Age, occupation, number of hospitalizations, type of medical insurance, Transfer to other departments, length of stay (LOS), type of UL, admission condition, comorbidities and complications, type of primary procedure, other types of surgical procedures, and discharge method had a significant impact on hospitalization costs (P<0.05). Among them, the type of primary procedure, other types of surgical procedures, and LOS were the main factors influencing hospitalization costs. By incorporating the type of primary procedure, other types of surgical procedures, and LOS into the decision tree model, patients were divided into 11 DRG combinations. Conclusion: Hospitalization costs for UL are mainly related to the type of primary procedure, other types of surgical procedures, and LOS. The DRG case combinations of UL based on E-CHAID algorithm are scientific and reasonable.

Indexed as

decision treediagnosis-related groupsuterine leiomyoma

Identifiers

PMID38444948
PMCPMC10913598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.